Back to search

Article

Prognostic value of the ratio of Interleukin-2 and Interleukin-10 in patients with hepatocellular carcinoma treated with anti-PD-1 therapy

2024-04-05

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>The progression of cancer is intricately linked to systemic immunity. However, within the hepatocellular carcinoma (HCC) patients undergoing anti-PD-1 therapy, there exists a paucity of comprehensive reports concerning the prognostic implications of immunological markers within peripheral blood. The primary objective of this investigation is to meticulously iden...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bf1cc8d3-f10e-5bf6-96f6-6a81b813bc21
DOI
10.21203/rs.3.rs-4098060/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic value of the ratio of Interleukin-2 and Interleukin-10 in patients with hepatocellular carcinoma treated with anti-PD-1 therapyDOI 10.21203/rs.3.rs-4098060/v1
Prognostic Value of the Ratio of Interleukin-2 and Interleukin-10 in Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Therapy.Semantic proximity
Construction and evaluation of clinical prediction model for immunotherapy-related adverse events and clinical benefit in cancer patients receiving immune checkpoint inhibitors based on serum cytokine levelsSemantic proximity
Lymphocyte subsets and inflammatory factors as predictors of immunotherapy efficacy in patients with hepatocellular carcinomaSemantic proximity
Characteristics and Hematological Indicators Predictors of Immunotherapy Response in Advanced Non-Small Cell Lung CancerSemantic proximity
Effect of PD-1 inhibitor combined with chemotherapy on cytokines and immune cell function in patients with advanced lung cancerSemantic proximity
Predictive value of the biomarker of peripheral blood of NSCLC patients responding to anti-PD-1 treatmentSemantic proximity
Immune Microenvironment and Clinical Significance of PD1 Expression in Hepatocellular Carcinoma PatientsSemantic proximity
Prognostic significance of the peripheral blood CD4/CD8 ratio in lung cancer patients: A meta-analysisSemantic proximity
Immune Cell Composition of Liver Hepatocellular Carcinoma and its clinical relevance: A research based on TCGA databaseSemantic proximity
The ratio of cytotoxic lymphocytes to M2-like macrophages is prognostic in immunogenic tumorsSemantic proximity
A Multi-stage Precision Stratification (MPS) Framework for Navigating Adjuvant Immunotherapy in Hepatocellular Carcinoma After ResectionSemantic proximity
Gut microbiota as a prognostic biomarker for unresectable hepatocellular carcinoma treated with anti-PD-1 therapySemantic proximity
Select a neighboring publication to make it the new centre.